Global Helicobacter Pylori Diagnostics Market Strategic Research Report

Scope of the Report

The global Helicobacter Pylori Diagnostics market size is predicted to grow from US$ 805 million in 2025 to US$ 1,296 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

This report presents a comprehensive overview of the global Helicobacter Pylori Diagnostics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Invasive Techniques
• Non-invasive Techniques

Segment by players, this report covers

• Sekisui Diagnostics
• F. Hoffmann-La Roche
• Medline Industries
• Meridian Bioscience
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Alpha Laboratories
• EKF Diagnostics
• Quidel
• Halyard Health
• Cardinal Health
• Beckman Coulter
• Agilent Technologies
• Coris BioConcept

Segment by Application

• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Helicobacter Pylori Diagnostics market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals and Clinics, Diagnostic Laboratories, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact